Medications for Metastatic Castrationsensitive Prostate Carcinoma

4 results

  • erleada - apalutamide tablet, film coated

    (Apalutamide)
    Janssen Products, Lp
    Erleada treats metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) in adult patients.
    Medication Details
    Drug Interactions

  • nubeqa - darolutamide tablet, film coated

    (Darolutamide)
    Bayer Healthcare Pharmaceuticals Inc.
    NUBEQA is an androgen receptor inhibitor for adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) or metastatic castration-sensitive prostate cancer (mCSPC), including mCSPC in combination with docetaxel.
    Medication Details
    Drug Interactions

  • xtandi - enzalutamide capsule

    (Enzalutamide)
    Astellas Pharma Us, Inc.
    Xtandi treats castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer (mCSPC), and non-metastatic castration-sensitive prostate cancer (nmCSPC) with high-risk biochemical recurrence.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • zytiga - abiraterone acetate tablet

    (Abiraterone Acetate)
    Janssen Biotech, Inc.
    ZYTIGA (abiraterone), with prednisone, treats metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adults.
    Medication Details
    Drug Interactions